UnitedHealth Group Incorporated (NYSE:UNH) Stake Increased by Wealthquest Corp

Wealthquest Corp raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 470 shares of the healthcare conglomerate’s stock after purchasing an additional 34 shares during the period. Wealthquest Corp’s holdings in UnitedHealth Group were worth $238,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $27,000. Global Wealth Strategies & Associates raised its holdings in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $32,000. Quarry LP lifted its holdings in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth approximately $37,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.1 %

UNH stock opened at $510.03 on Tuesday. The company’s 50 day simple moving average is $549.37 and its 200-day simple moving average is $563.70. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $469.37 billion, a P/E ratio of 32.91, a P/E/G ratio of 1.39 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the firm posted $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.77 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group’s payout ratio is 54.19%.

Analysts Set New Price Targets

UNH has been the topic of a number of recent research reports. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, January 15th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Stephens raised their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.